-
Je něco špatně v tomto záznamu ?
Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation
Z. Ambrůzová, F. Mrázek, L. Raida, A. Sťahelová, E. Faber, K. Indrák, M. Petřek
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem
Grantová podpora
NR9099
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- dospělí MeSH
- homologní transplantace MeSH
- imunoglobuliny genetika MeSH
- jednonukleotidový polymorfismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mukoproteiny genetika MeSH
- multivariační analýza MeSH
- nemoc štěpu proti hostiteli genetika mortalita MeSH
- transplantace hematopoetických kmenových buněk škodlivé účinky MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) contributes to the recruitment of donor T cells into the mucosal tissues of the recipient after allogeneic hematopoietic stem cell transplantation (aHSCT). The aim of our study was to determine whether selected single nucleotide polymorphisms (SNPs) of the MADCAM1 gene are associated with development of serious complications after aHSCT. Three MADCAM1 gene single nucleotide polymorphisms (rs758502 C/T, rs2302217 A/G, rs3745925 G/T) were genotyped by polymerase chain reaction with sequence-specific primers in 87 Czech, HLA-identical donor-recipient aHSCT pairs. MADCAM1 rs2302217 AA homozygous recipients developed chronic GVHD more frequently than patients with other genotypes (65% vs. 34%; p = 0.025). Furthermore, multivariate analysis revealed the MADCAM1 rs2302217 AA genotype in recipient being also an independent factor associated with development of acute GVHD (p = 0.036) and decreased overall survival (p = 0.001). These data suggest that MADCAM1 gene polymorphisms may be associated with the risk of chronic GVHD and may, also, affect mortality related to aHSCT.
- 000
- 02865naa 2200469 a 4500
- 001
- bmc11016927
- 003
- CZ-PrNML
- 005
- 20140721151636.0
- 008
- 110628s2009 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ambrůzová, Zuzana $7 xx0072990 $u Laboratory of Immunogenomics and Proteomics, Department of Immunology, Palacky University and University Hospital Olomouc, Czech Republic
- 245 10
- $a Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation / $c Z. Ambrůzová, F. Mrázek, L. Raida, A. Sťahelová, E. Faber, K. Indrák, M. Petřek
- 314 __
- $a Laboratory of Immunogenomics and Proteomics, Department of Immunology, Palacky University and University Hospital, Olomouc, Czech Republic.
- 520 9_
- $a Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) contributes to the recruitment of donor T cells into the mucosal tissues of the recipient after allogeneic hematopoietic stem cell transplantation (aHSCT). The aim of our study was to determine whether selected single nucleotide polymorphisms (SNPs) of the MADCAM1 gene are associated with development of serious complications after aHSCT. Three MADCAM1 gene single nucleotide polymorphisms (rs758502 C/T, rs2302217 A/G, rs3745925 G/T) were genotyped by polymerase chain reaction with sequence-specific primers in 87 Czech, HLA-identical donor-recipient aHSCT pairs. MADCAM1 rs2302217 AA homozygous recipients developed chronic GVHD more frequently than patients with other genotypes (65% vs. 34%; p = 0.025). Furthermore, multivariate analysis revealed the MADCAM1 rs2302217 AA genotype in recipient being also an independent factor associated with development of acute GVHD (p = 0.036) and decreased overall survival (p = 0.001). These data suggest that MADCAM1 gene polymorphisms may be associated with the risk of chronic GVHD and may, also, affect mortality related to aHSCT.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a nemoc štěpu proti hostiteli $x genetika $x mortalita $7 D006086
- 650 _2
- $a transplantace hematopoetických kmenových buněk $x škodlivé účinky $7 D018380
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoglobuliny $x genetika $7 D007136
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mukoproteiny $x genetika $7 D009088
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a homologní transplantace $7 D014184
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mrázek, František, $d 1973- $7 xx0051697 $u Laboratory of Immunogenomics and Proteomics, Department of Immunology, Palacky University and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Raida, Luděk, $d 1968- $7 xx0034365 $u Department of Hematooncology, Palacky University and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Sťahelová, Anna $7 xx0159629 $u Laboratory of Immunogenomics and Proteomics, Department of Immunology, Palacky University and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Faber, Edgar, $d 1956- $7 xx0062699 $u Department of Hematooncology, Palacky University and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Indrák, Karel, $d 1947- $7 jn20000401162 $u Department of Hematooncology, Palacky University and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Petřek, Martin, $d 1963- $7 jn20000401972 $u Laboratory of Immunogenomics and Proteomics, Department of Immunology, Palacky University and University Hospital Olomouc, Czech Republic
- 773 0_
- $t Human Immunology $g Roč. 70, č. 6 (2009), s. 457-460 $w MED00002076
- 910 __
- $a ABA008 $b B 1603 $y 2 $z 0
- 990 __
- $a 20110720094854 $b ABA008
- 991 __
- $a 20140721151943 $b ABA008
- 999 __
- $a ok $b bmc $g 864140 $s 726719
- BAS __
- $a 3
- BMC __
- $a 2009 $b 70 $c 6 $d 457-460 $m Human immunology $n Hum Immunol $x MED00002076
- GRA __
- $a NR9099 $p MZ0
- LZP __
- $a 2011-3B09/BBjvme